193 related articles for article (PubMed ID: 21130636)
21. Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters.
Stein BD; Charbeneau JT; Lee TA; Schumock GT; Lindenauer PK; Bautista A; Lauderdale DS; Naureckas ET; Krishnan JA
COPD; 2010 Jun; 7(3):164-71. PubMed ID: 20486814
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with hospital admission among emergency department patients with chronic obstructive pulmonary disease exacerbation.
Tsai CL; Clark S; Cydulka RK; Rowe BH; Camargo CA
Acad Emerg Med; 2007 Jan; 14(1):6-14. PubMed ID: 17119187
[TBL] [Abstract][Full Text] [Related]
23. An integrated care facilitation model improves quality of life and reduces use of hospital resources by patients with chronic obstructive pulmonary disease and chronic heart failure.
Bird S; Noronha M; Sinnott H
Aust J Prim Health; 2010; 16(4):326-33. PubMed ID: 21138701
[TBL] [Abstract][Full Text] [Related]
24. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.
Toy EL; Gallagher KF; Stanley EL; Swensen AR; Duh MS
COPD; 2010 Jun; 7(3):214-28. PubMed ID: 20486821
[TBL] [Abstract][Full Text] [Related]
25. Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010.
de Miguel-Díez J; Jiménez-García R; Hernández-Barrera V; Puente-Maestu L; Rodríguez-Rodríguez P; López de Andrés A; Carrasco-Garrido P
Respir Med; 2013 May; 107(5):717-23. PubMed ID: 23421969
[TBL] [Abstract][Full Text] [Related]
26. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
Suh DC; Lau H; La HO; Choi IS; Geba GP
Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
[TBL] [Abstract][Full Text] [Related]
27. US hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional host.
Patel DA; Gao X; Stephens JM; Forshag MS; Tarallo M
J Med Econ; 2011; 14(2):227-37. PubMed ID: 21385144
[TBL] [Abstract][Full Text] [Related]
28. Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease--a population-based study.
Ekberg-Aronsson M; Löfdahl K; Nilsson JA; Löfdahl CG; Nilsson PM
Respir Med; 2008 Jan; 102(1):109-20. PubMed ID: 17928213
[TBL] [Abstract][Full Text] [Related]
29. A Scandinavian audit of hospitalizations for chronic obstructive pulmonary disease.
Liaaen ED; Henriksen AH; Stenfors N
Respir Med; 2010 Sep; 104(9):1304-9. PubMed ID: 20363605
[TBL] [Abstract][Full Text] [Related]
30. Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations.
Laurin C; Labrecque M; Dupuis G; Bacon SL; Cartier A; Lavoie KL
Psychosom Med; 2009 Jul; 71(6):667-74. PubMed ID: 19561164
[TBL] [Abstract][Full Text] [Related]
31. [Cost analysis for inpatient therapy for patients with acute exacerbations of chronic obstructive pulmonary disease].
Motegi T; Yamada K; Kida K
Nihon Kokyuki Gakkai Zasshi; 2006 Nov; 44(11):787-94. PubMed ID: 17144574
[TBL] [Abstract][Full Text] [Related]
32. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations].
Jahnz-Rózyk K; Targowski T; From S; Płusa T
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():91-4. PubMed ID: 15524028
[TBL] [Abstract][Full Text] [Related]
33. Preventing hospitalization for COPD exacerbations.
Bourbeau J
Semin Respir Crit Care Med; 2010 Jun; 31(3):313-20. PubMed ID: 20496300
[TBL] [Abstract][Full Text] [Related]
34. [What are the socio-economic consequences of acute COPD exacerbations?].
Bourdin A; Molinari N
Rev Mal Respir; 2017 Apr; 34(4):338-342. PubMed ID: 28476415
[No Abstract] [Full Text] [Related]
35. Clinical and economic analysis of antimicrobial therapy of chronic obstructive pulmonary disease exacerbations.
Simoens S; Decramer M; De Coster S; Celis G; Laekeman G
Int J Clin Pract; 2007 Feb; 61(2):200-6. PubMed ID: 17263707
[TBL] [Abstract][Full Text] [Related]
36. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991.
Jacobson L; Hertzman P; Löfdahl CG; Skoogh BE; Lindgren B
Respir Med; 2000 Mar; 94(3):247-55. PubMed ID: 10783936
[TBL] [Abstract][Full Text] [Related]
37. The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls.
Bilde L; Rud Svenning A; Dollerup J; Baekke Borgeskov H; Lange P
Respir Med; 2007 Mar; 101(3):539-46. PubMed ID: 16889949
[TBL] [Abstract][Full Text] [Related]
38. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease.
Patil SP; Krishnan JA; Lechtzin N; Diette GB
Arch Intern Med; 2003 May; 163(10):1180-6. PubMed ID: 12767954
[TBL] [Abstract][Full Text] [Related]
39. Acute care costs of patients admitted for management of chronic obstructive pulmonary disease exacerbations: contribution of disease severity, infection and chronic heart failure.
Hutchinson A; Brand C; Irving L; Roberts C; Thompson P; Campbell D
Intern Med J; 2010 May; 40(5):364-71. PubMed ID: 20180870
[TBL] [Abstract][Full Text] [Related]
40. Excessive costs of COPD in ever-smokers. A longitudinal community study.
Nielsen R; Johannessen A; Omenaas ER; Bakke PS; Askildsen JE; Gulsvik A
Respir Med; 2011 Mar; 105(3):485-93. PubMed ID: 21030232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
